Findings

What do systematic reviews say?

1,133 questions · 1,153 findings · 36 reviews · Skin

Sort:Best matchNewest Highest certainty Download CSV

No studies found 407 · 35.3%GRADE not reported 90 · 7.8%Very low 183 · 15.9%Low 209 · 18.1%Moderate 211 · 18.3%High 53 · 4.6%

Clarithromycin vs placebo

Minor adverse events not leading to withdrawal of treatment · pityriasis rosea

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for pityriasis rosea 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Erythromycin vs placebo

The proportion of participants with good or excellent rash improvement within 2 weeks, as rated by the participant · pityriasis rosea

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for pityriasis rosea 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Erythromycin vs placebo

Serious adverse events, i.e. serious enough to require withdrawal of the treatment · pityriasis rosea

1 finding from 1 review

Interventions for pityriasis rosea 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 34 participants
Moderate

Erythromycin vs placebo

The proportion of participants with resolution of itch within 2 weeks, as rated by the participant · pityriasis rosea

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for pityriasis rosea 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Biotin vs placebo

Change in severity · infantile seborrhoeic dermatitis (including cradle cap)

1 finding from 1 review

Interventions for infantile seborrhoeic dermatitis (including cradle cap) 2019 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 39 participants
Very low

Biotin vs placebo

Adverse events · infantile seborrhoeic dermatitis (including cradle cap)

1 finding from 1 review

Interventions for infantile seborrhoeic dermatitis (including cradle cap) 2019 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 39 participants
GRADE not reported

Biotin vs placebo

Quality of life · infantile seborrhoeic dermatitis (including cradle cap)

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for infantile seborrhoeic dermatitis (including cradle cap) 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Proprietary products vs placebo

Change in severity · infantile seborrhoeic dermatitis (including cradle cap)

1 finding from 1 review

Interventions for infantile seborrhoeic dermatitis (including cradle cap) 2019 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 166 participants
Very low

Proprietary products vs placebo

Adverse events · infantile seborrhoeic dermatitis (including cradle cap)

1 finding from 1 review

Interventions for infantile seborrhoeic dermatitis (including cradle cap) 2019 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 166 participants
Very low

Proprietary products vs placebo

Quality of life · infantile seborrhoeic dermatitis (including cradle cap)

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for infantile seborrhoeic dermatitis (including cradle cap) 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Topical steroid vs comparator

Change in severity · infantile seborrhoeic dermatitis (including cradle cap)

1 finding from 1 review

Interventions for infantile seborrhoeic dermatitis (including cradle cap) 2019 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 105 participants
Very low

Topical steroid vs comparator

Adverse events · infantile seborrhoeic dermatitis (including cradle cap)

1 finding from 1 review

Interventions for infantile seborrhoeic dermatitis (including cradle cap) 2019 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 105 participants
Very low

Topical steroid vs comparator

Quality of life · infantile seborrhoeic dermatitis (including cradle cap)

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for infantile seborrhoeic dermatitis (including cradle cap) 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intravenous soya oil‐derived (n‐6) fatty acid‐based lipid emulsion vs intravenous fish oil‐derived (n‐3) fatty acid‐based lipid emulsion

Proportion of participants achieving clear or almost clear skin (PASI 90 to 100 or PGA 0 to 1) · guttate psoriasis

The review found no eligible studies for this question.

1 finding from 1 review

Non‐antistreptococcal interventions for acute guttate psoriasis or an acute guttate flare of chronic psoriasis 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intravenous soya oil‐derived (n‐6) fatty acid‐based lipid emulsion vs intravenous fish oil‐derived (n‐3) fatty acid‐based lipid emulsion

Percentage of participants with adverse effects and severe adverse effects · guttate psoriasis

The review found no eligible studies for this question.

1 finding from 1 review

Non‐antistreptococcal interventions for acute guttate psoriasis or an acute guttate flare of chronic psoriasis 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intravenous soya oil‐derived (n‐6) fatty acid‐based lipid emulsion vs intravenous fish oil‐derived (n‐3) fatty acid‐based lipid emulsion

Number of relapses of guttate psoriasis or flares within a period of 6 months after the treatment has finished · guttate psoriasis

The review found no eligible studies for this question.

1 finding from 1 review

Non‐antistreptococcal interventions for acute guttate psoriasis or an acute guttate flare of chronic psoriasis 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intravenous soya oil‐derived (n‐6) fatty acid‐based lipid emulsion vs intravenous fish oil‐derived (n‐3) fatty acid‐based lipid emulsion

Proportion of participants achieving PASI 75 or PGA 1 to 2 · guttate psoriasis

The review found no eligible studies for this question.

1 finding from 1 review

Non‐antistreptococcal interventions for acute guttate psoriasis or an acute guttate flare of chronic psoriasis 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intravenous soya oil‐derived (n‐6) fatty acid‐based lipid emulsion vs intravenous fish oil‐derived (n‐3) fatty acid‐based lipid emulsion

Improvement in participant satisfaction measures and quality of life assessment measures Overall subjective score on 5 items (appearance of lesions, impairment of daily life, pruritus, burning, and pain) reported through figures · guttate psoriasis

1 finding from 1 review

Non‐antistreptococcal interventions for acute guttate psoriasis or an acute guttate flare of chronic psoriasis 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 21 participants
Very low

Penicillin vs no treatment

Time‐to‐resolution: achieving PASI 90 to 100 or PGA 0 to 1 · guttate psoriasis

The review found no eligible studies for this question.

1 finding from 1 review

Antistreptococcal interventions for guttate and chronic plaque psoriasis 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Erythromycin vs no treatment

Relapse · guttate psoriasis

The review found no eligible studies for this question.

1 finding from 1 review

Antistreptococcal interventions for guttate and chronic plaque psoriasis 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found